Physician profile
Christopher W Digiovanni
NPI 1699715920
$665,475.26
in general payments reported to CMS, 2019-2025
10 companies · $113K in 2025
The $113K reported for 2025 was more than what 95% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $51K · 2021: $74K · 2022: $90K · 2023: $179K · 2024: $86K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $196K · Royalty Or License: $179K · Travel and Lodging: $2,778 · Food and Beverage: $47.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $196,247.61 |
| Royalty Or License | $178,552.00 |
| Travel and Lodging | $2,778.24 |
| Food and Beverage | $47.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Extremity Medical | $469,495.83 | 2019-2025 | Xmcp, Io Fix, Jones |
| Orthofix Medical, INC. | $150,752.10 | 2019-2025 | Osteostrand, Strand, Physio-Stim |
| Wright Medical Technology, INC. | $17,031.66 | 2019-2020 | |
| Seaspine Orthopedics Corporation | $11,321.95 | 2022 | |
| Ossio INC | $10,193.50 | 2021-2024 | |
| Stryker Corporation | $3,207.62 | 2020-2024 | |
| Arthrex, INC. | $1,921.78 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $1,500.00 | 2020 | |
| Treace Medical Concepts, INC. | $50.82 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$934,345.88 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Digiovanni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.